Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.
Saved in:
| Title: | Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study. |
|---|---|
| Authors: | Diamantopoulos, Panagiotis T., Stafylidis, Christos, Vlachopoulou, Dimitra, Kontandreopoulou, Christina-Nefeli, Giannakopoulou, Nefeli, Vardaka, Maria, Mpouhla, Anthi, Mastrogianni, Elpida, Variami, Eleni, Galanopoulos, Athanasios, Pappa, Vasiliki, Psichogiou, Mina, Hatzakis, Angelos, Viniou, Nora-Athina |
| Source: | Therapeutic advances in hematology 5/23/2022; Vol. 13. |
| Journal Info: | Publisher: Sage Publications Inc. ISSN: 2040-6207 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2040-6215 |
|---|---|
| DOI: | 10.1177/20406207221090150 |
